‘Public-private’ deal heralds revolution in search for new drug treatments

GlaxoSmithKline and non-profit institutes hope to fast-track research into cures using patient DNA

Science Editor

Britain’s biggest drug company has signed a pioneering deal with two public research institutes to develop new medicines based on patient DNA in the hope of discovering lucrative treatments for a range of illnesses with a genetic basis, from cancer to heart disease.

GlaxoSmithKline (GSK) has promised to publicly release any early research findings for free in return for the expertise and help offered by the Wellcome Trust Sanger Institute, where the human genome was decoded, and the European Bioinformatics Institute (EBI), both based on the same campus in Cambridge.

The aim of the unique collaboration is to identify potential targets in the body for new drugs based on an analysis of the huge volumes of data generated by the human genome and similar studies into complex biological molecules such as proteins and peptides.

In return for its investment, GSK hopes to steal a march on its competitors by identifying targets early enough for it to develop drugs that have less risk of failure at the early stages of clinical trials, said Ewan Birney, associate director of the EBI and the interim head of the new Centre for Therapeutic Target Validation.

“This is about enlightened self-interest. They are funding public research to do the groundwork in the earliest stage of drug discovery. They really want to change the game for this early part of the drug-discovery process,” Dr Birney said.

“They are backing themselves that they can do the next phase and find the right drug that works better than anyone else. They realised that some things are better solved in the public domain,” he said.

One of the preconditions of the collaboration is that the research findings will be freely available, but GSK can direct the research towards areas where the company already has a commercial interest, Dr Birney said.

It is estimated that about nine out of 10 potential new drugs fail when they enter clinical trials even though they have shown promise in the laboratory and in animal trials. 

Another problem is that even many licensed drugs do not work on all potential patients - some people do not respond because of their genetic makeup. It is one of the best-kept secrets of the pharmaceuticals industry that most of the drugs it makes do not work on most of the patients they are designed for.

“We are interested in knowing the proteins to target for drugs. In the case of responders and non-responders, were interested really in the new proteins in the non-responders which look like the right ones to target,” Dr Birney said.

The Sanger Institute is a world leader in decoding and analysing genome data while the EBI’s area of expertise is handling the huge volume of data generated by genome science, as well as new research in proteomics (proteins science), biochemistry and the biological basis of disease.

The centre will be built on the same site in Cambridge where the Sanger Institute is based and will initially employ about 50 researchers.

Patrick Vallance, president of pharmaceuticals research and development at GSK, said that by changing its business model and sharing information in a collaborative way, the company hopes to accelerate the development of new medicines.

“Target validation is one of the greatest challenges in drug discovery. We need to understand better the mechanisms in our body related to disease to improve how we can develop the most effective mechanisms,” Dr Vallance said.

Professor Sir Mike Stratton, director of the Sanger Institute, said: “Advances in genomics have led to a rapid increase in the availability of drug targets, providing enormous opportunity but also posing the problem of how we best convert this knowledge into medicines.

“The challenge we now address it to identify those new targets with the greatest relevance to human disease which, in turn, will undoubtedly increase the speed and efficiency in which new medicines can be developed.”

Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
Brendan O'Carroll as Agnes Brown in the 2014 Mrs Brown's Boys Christmas special
tvCould Mrs Brown's Boys have taken lead for second year?
News
Members and supporters of the lesbian, gay, bisexual, transgender (LGBT) community walk with a rainbow flag during a rally in July
news
Sport
Chelsea midfielder Cesc Fabregas
footballChelsea vs West Ham live kicks off coverage of all 10 of Boxing Day matches
News
peopleIt seems you can't silence Katie Hopkins, even on Christmas Day...
PROMOTED VIDEO
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
News
i100
Arts and Entertainment
Jack O'Connell stars as Louis Zamperini in Angelina Jolie's Unbroken
film review... even if Jack O'Connell is excellent
Arts and Entertainment
Madonna is not in Twitter's good books after describing her album leak as 'artistic rape and terrorism'
music14 more 'Rebel Heart' tracks leaked including Pharrell Williams collaboration
News
news
Arts and Entertainment
Wolf (Nathan McMullen), Ian (Dan Starky), The Doctor (Peter Capaldi), Clara (Jenna Coleman), Santa Claus (Nick Frost) in the Doctor Who Christmas Special (BBC/Photographer: David Venni)
tvOur review of the Doctor Who Christmas Special
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Ashdown Group: Senior Marketing Executive- City of London, Old Street

£40000 - £43000 per annum + benefits: Ashdown Group: Senior Marketing Executiv...

Ashdown Group: Marketing Manager

£40000 - £43000 per annum + benefits: Ashdown Group: An international organisa...

Ashdown Group: Internal Recruiter -Rugby, Warwickshire

£25000 - £30000 per annum: Ashdown Group: Internal Recruiter -Rugby, Warwicksh...

Ashdown Group: Marketing Manager/Marketing Controller (Financial Services)

£70000 - £75000 per annum + benefits: Ashdown Group: Marketing Manager/Marketi...

Day In a Page

A Christmas without hope: Fears grow in Gaza that the conflict with Israel will soon reignite

Christmas without hope

Gaza fears grow that conflict with Israel will soon reignite
After 150 years, you can finally visit the grisliest museum in the country

The 'Black Museum'

After 150 years, you can finally visit Britain's grisliest museum
No ho-ho-hos with Nick Frost's badass Santa

No ho-ho-hos with Nick Frost's badass Santa

Doctor Who Christmas Special TV review
Chilly Christmas: Swimmers take festive dip for charity

Chilly Christmas

Swimmers dive into freezing British waters for charity
Veterans' hostel 'overwhelmed by kindness' for festive dinner

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Isis in Iraq: Yazidi girls killing themselves to escape rape and imprisonment by militants

'Jilan killed herself in the bathroom. She cut her wrists and hanged herself'

Yazidi girls killing themselves to escape rape and imprisonment
Ed Balls interview: 'If I think about the deficit when I'm playing the piano, it all goes wrong'

Ed Balls interview

'If I think about the deficit when I'm playing the piano, it all goes wrong'
He's behind you, dude!

US stars in UK panto

From David Hasselhoff to Jerry Hall
Grace Dent's Christmas Quiz: What are you – a festive curmudgeon or top of the tree?

Grace Dent's Christmas Quiz

What are you – a festive curmudgeon or top of the tree?
Nasa planning to build cloud cities in airships above Venus

Nasa planning to build cloud cities in airships above Venus

Planet’s surface is inhospitable to humans but 30 miles above it is almost perfect
Surrounded by high-rise flats is a little house filled with Lebanon’s history - clocks, rifles, frogmen’s uniforms and colonial helmets

Clocks, rifles, swords, frogmen’s uniforms

Surrounded by high-rise flats is a little house filled with Lebanon’s history
Return to Gaza: Four months on, the wounds left by Israel's bombardment have not yet healed

Four months after the bombardment, Gaza’s wounds are yet to heal

Kim Sengupta is reunited with a man whose plight mirrors the suffering of the Palestinian people
Gastric surgery: Is it really the answer to the UK's obesity epidemic?

Is gastric surgery really the answer to the UK's obesity epidemic?

Critics argue that it’s crazy to operate on healthy people just to stop them eating
Homeless Veterans appeal: Christmas charity auction Part 2 - now LIVE

Homeless Veterans appeal: Christmas charity auction

Bid on original art, or trips of a lifetime to Africa or the 'Corrie' set, and help Homeless Veterans
Pantomime rings the changes to welcome autistic theatre-goers

Autism-friendly theatre

Pantomime leads the pack in quest to welcome all